Full Access
REFERENCES
First published: August 1972

References
- Allikmets, L. H. & I. P. Lapin (1967): Influence of lesions of the amygdaloid complex on behaviour and on effects of antidepressants in rats. Int. J. Neuropharmacol. 6, 99–108.
- Amsler, C. (1923): Beiträge zur Pharmakologie des Gehirns. Arch. exp. Pathol. Pharmakol. 97, 1–14.
- Andén, N.-E. (1970): Effects of amphetamine and some other drugs on central catecholamine mechanisms. Symposium on Amphetamines and Related Compounds. ( E. Costa and S. Garattini, Eds.). Raven Press, New York , 447–479.
- Andén, N.-E., B. E. Roos & B. Werdinius (1964): Effects of chlorpromazine, haloperidol and reserpine on the levels of phenolic acids in rabbit corpus striatum. Life Sci. 3, 149–158.
- Andén, N.-E., A. Dahlström, K. Fuxe, K. Larsson, L. Olsson & U. Ungerstedt (1966): Ascending monoamine neurons to the telencephalon and diencephalon. Acta Physiol. Scand. 67, 313–326.
- Andén, N.-E., G. Bartholini, H. Corrodi, B. Csillik, E. de Robertis, A. Dresse, K. Fuxe, M. A. Gerebtzoff, J. Glowinski, E. Hansson, T. Hökfelt, J. Renson & B. E. Roos (1970): Histological and molecular biochemistry. In: Modern Problems of Pharmacopsychiatry (Neuroleptics). ( J. Bobon and P. Janssen, Eds.). Karger, Basel , 1–11.
- Arbuthnott, G. W. & U. Ungerstedt (1969): Locomotor behaviour after electrical stimulation of dopamine containing neurons. Acta Physiol. Scand., suppl. 330, 117.
- Arnfred, T. & A. Randrup (1968): Cholinergic mechanisms in brain inhibiting amphetamine-induced stereotyped behaviour. Acta Pharmacol. Toxicol. 26, 384–394.
- Ashcroft, G. W., D. Eccleston & J. L. Waddell (1965): Recognition of amphetamine addicts. Brit. med. J. 1, 57–59.
- Bättig, K. (1963): Differential psychopharmacological patterns of action in rats. In: Psychopharmacological Methods ( Z. Votava, Ed.). Pergamon Press, London , 151–161.
- Belart, W. (1942): Pathogenetisches und Therapeutisches aus Pervitinversuchen bei Schizophrenic. Schweiz. med. Woch.-schr. 72 41–46.
-
Beringer, K. (1927): Der Meskalinrausch. Springer Verlag,
Berlin
.
10.1007/978-3-662-11451-3 Google Scholar
- Bertler, Å. & E. Rosengren (1959): Occurrence and distribution of dopamine in brain and other tissues. Acta Physiol. Scand. 47, 350–361.
- Bertler, Å. & E. Rosengren (1966): Possible role of brain dopamine. Pharmacol. Rev. 18, 769–773.
- Bertler, Å., B. Falck, C. G. Gottfries, L. Ljunggren E. Rosengren (1964): Some observations on adrenergic connection between mesencephalon and cerebral hemispheres. Acta Pharmacol. Toxicol. 21, 283–289.
- Binet, L., R. Cahen, J. Nadand & J.-F. Clément (1962): Étude comparé de divers modificateurs du système nerveux central sur le cyprin. C. R. Acad. Sci. (Paris) 254, 3284–3287.
- Bleuler, E. (1961): Dementia praecox or the group of schizophrenias. International Universities Press, New York .
- J. Bobon, & P. Janssen, (Eds.) (1970): Modern Problems of Pharmacopsychiatry, Symposium on Neuroleptics. Karger, Basel , 1–172.
- Brodie, B. B., G. L. Gessa & E. Costa (1962): Association between reserpine syndrome and blockade of brain serotonin storage processes. Life Sci. 1, 551–560.
- Brown, H. (1963): d-amphetamine-chlorpromazine antagonism in a food reinforced operant. J. exp. Analysis Behav. 6, 395–398.
- Brown, J. W. (1967): Physiology and phylogenesis of emotional expression. Brain Res 5, 1–14.
- Bunney, W., D. Janowsky, F. Goodwin, J. Davis, H. Brodie, D. Murphy & T. Chase (1969): Effect of 1-dopa on depression. Lancet 1, 885–886.
-
Carlsson, A. (1964): Functional significance of drug-induced changes in brain monoamine levels. In: Biogenic Amines, vol. 18 ( H. Himwich &
W. Himwich, Eds.). Elsevier,
Amsterdam
.
10.1016/S0079-6123(08)60110-7 Google Scholar
- Carlsson, A. (1966): Morphologic and dynamic aspects of dopamine in the central nervous system. In: Biochemistry and Pharmacology of the Basal Ganglia ( E. Costa, L. Coté and M. Yahr, Eds.). Raven Press N. Y. 107–114.
- Carlsson, A. (1970): Amphetamine and brain catecholamines. Symposium on Amphetamines and Related Compounds. ( E. Costa and S. Garattini, Eds.). Raven Press, N. Y. 289–300.
- Carlsson, A. & M. Lindquist (1963): Effect of chlorpromazine and haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol. Toxicol. 20, 140–144.
- Carlsson, A., M. Lindquist & T. Magnusson (1957): 3,4-dihydroxyphenylalanine and 5-hydroxytryptophane as reserpine antagonists. Nature (Lond.) 180, 1200.
- Carlsson, A., M. Lindquist, A. Dahlström, K. Fuxe & D. Masuoka (1965): Effects of the amphetamine group on intraneuronal brain amines in vivo and in vitro. J. Pharm. Pharmacol. 17, 521–524.
- Carlsson, A., M. Lindquist, K. Fuxe & B. Hamberger (1966 a): The effect of (+)-amphetamine on various central and peripheral catecholamine-containing neurons. J. Pharm. Pharmacol. 18, 128–130.
- Carlsson, A., K. Fuxe, B. Hamberger & M. Lindquist (1966b): Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons. Acta Physiol. Scand. 67, 481–497.
- Carlsson, A., K. Fuxe & T. Hökfelt (1967): Failure of dopamine to accumulate in central noradrenaline neurons after depletion with diethyldithiocarbamate. J. Pharm. Pharmac. 19 (7), 481–483.
- Carlton, P. (1961): Some effects of scopolamine, atropine and amphetamine in three behavioural situations. Pharmacologist 3, 60.
-
Chalmers, R. K. &
C. K. Erickson (1964): Central cholinergic blockade of the conditioned avoidance response in rats.
Psychopharmacologia
6, 31–41.
10.1007/BF00710912 Google Scholar
- Chance, M. (1948): A peculiar form of social behaviour induced in mice by amphetamine. Behaviour 1, 64–69.
- Chance, M. & A. Silverman (1964): The structure of social behaviour and drug action. In: Animal Behaviour and Drug Action. ( H. Steinberg, A. Reuck and J. Knight, Eds.) Churchill, London .
- Clark, F. C. & B. J. Steele (1966): Effects of d-amphetamine on performance under a multiple schedule in the rat. Psychopharmacologia (Berl.) 9, 157–169.
- Connell, P. H. (1958): Amphetamine Psychosis. Maudsley Monograph No. 5, Chapman & Hall, London .
- Coppen, A. (1969): Defects in monoamine metabolism and their possible importance in the pathogenesis of depressive syndromes. Psychiat. Neurol. Neurochir. (Amst.) 72, 173–180.
- Costa, E. O., L. J. Coté, M. C. Yahr (1966): Biochemistry and Pharmacology of the Basal Ganglia. Raven Press, N. Y. , 1–215.
- Cotzias, G., M. van Woert & Schiffer (1967): Aromatic amino acids and modification of parkinsonism. New Engl. J. Med. 276, 374–378.
- Dahlström, A. & K. Fuxe (1965): Evidence for the existence of monoamine neurons in the central nervous system. Acta Physiol. Scand. 64, suppl. 247.
- Delay, J., P. Deniker & J. M. Harl (1952): Traitement des états d'excitation et d'agitation par une méthode medicamenteuse dérivée de l'hibernothérapie. Ann. med Psychol. 110, 267–273.
- Dresse, A. (1967): Contribution expérimentale à l'étude du mécanisme d'action des neuroleptiques. Thesis Liège.
- Ehrich, W. & E. Krumbhaar (1937): The effects of large doses of benzedrine sulphate on the albino rat: functional and tissue changes. Ann. intern. Med. 10, 1874–1882.
- Ellinwocd, E. H., Jr. (1967): Amphetamine psychosis: I Description of the individuals and process. J. nerv. ment. Dis. 144, 273–283.
- Emele, J., J. Shanaman & M. Warren (1961): Chlorphentermine hydrochloride, p.-chlor-α-α-dimethylphen-ethylamine hydrochloride, a new anorexigenic agent. II. Central nervous system activity. Fed. Proc. 20, 328.
- Ernst, A. M. (1967): Mode of action of apomorphine and dexamphetamine in gnawing compulsion in rats. Psychopharmacologia (Berl.) 10, 316–323.
- Ernst, A. M. & P. Smelik (1966): Site of action of dopamine and apomorphine on compulsive gnawing behaviour in rats. Experientia 22 (12), 837–838.
- Everett, G. M. & R. G. Wiegand (1962): Central amines and behavioral states: a critique and new data. First International Pharmacological Meeting ( W. D. M. Paton, Ed.). 85–92. Pergamon Press, Oxford .
- Everett, G. M., R. G. Wiegand & F. U. Rinaldi (1963): Pharmacologic studies of some nonhydrazine MAO-inhibitors. Ann. N. Y. Acad. Sci. 107, 1068–1080.
- Faurbye, A. (1968): The role of amines in the etiology of schizophrenia. Comprehensive Psychiatry 9, 155–177.
- Faurbye, A. & K. Pind (1964): Investigation on the occurrence of the dopamine metabolite 3,4-DMPEA in the urine of schizophrenics. Acta Psychiat. Scand. 40, 240–243.
- Fitz-Gerald, F. (1964): Effects of drugs upon stereotyped behavior in isolation reared chimpanzees. Paper read at the Meeting of American Association for Advancement of Science, Montreal, December 1964.
- Fitz-Gerald, F. (1967): Effects of d-amphetamine upon behavior of young chimpanzees reared under different conditions. Proceedings of the Fifth International Congress of Neuro-Psychopharmacology. ( H. Brill, J. O. Cole, P. Deniker, H. Hippius and P. B. Bradley, Eds.) Elsevier, Amsterdam , 1226.
-
Fog, R. (1967): Role of the corpus striatum in typical behavioural effects in rats produced by both amphetamine and neuroleptic drugs.
Acta Pharmacol. Toxicol.
25, suppl. 4, 59.
10.1111/j.1600-0773.1967.tb03046.x Google Scholar
- Fog, R. (1969 a): Rage reactions produced in rats by a combination of thymoleptics and monoamine oxidase inhibitors. Pharmacol. Res. Communic. 1, 79–84.
- Fog, R. (1969 b): Stereotyped and non-stereotyped behaviour in rats induced by various stimulant drugs. Psychopharmacologia (Berl.) 14, 299–304.
- Fog, R. (1970): Behavioural effects in rats of morphine and amphetamine and of combination of the two drugs. Psychopharmacologia (Berl.) 16, 305–312.
- Fog, R. & H. Pakkenberg (1970 a): Combined nitoman-pimozide treatment of Huntington's chorea and other hyperkinetic syndromes. Acta Neurol. Scand. 46, 249–251.
- Fog, R. & H. Pakkenberg (1970 b): Lesions in corpus striatum and cortex of rat brains and the effect on pharmacologically induced stereotyped, aggressive and cataleptic behaviour. Psychopharmacologia (Berl.) 18, 346–356.
- Fog, R. & H. Pakkenberg (1971 a). Behavioural effects of dopamine and p-hydroxyamphetamine injected into corpus striatum of rats. Exp. Neurol. 31 (1), 75–86.
- Fog, R. & H. Pakkenberg (1971 b): Intracerebral lesions causing stereotyped behaviour in rats. Acta Neurol. Scand. 47, 475–484.
- Fog, R., A. Randrup & I. Munkvad (1966 a): Dependence of the amphetamine excitatory response upon amines in the corpus striatum. Excerpta medica international Congress Series no. 117, 462.
- Fog, R., A. Randrup, & H. Pakkenberg (1966 b): Amines in the corpus striatum associated with the effects of both amphetamine and antipsychotic drugs. Proceedings of the IV World Congress of Psychiatry ( J. J. Lopez-Ibor, Ed.) Elsevier, Amsterdam , 2580–2582.
- Fog, R., A. Randrup, & H. Pakkenberg (1967): Aminergic mechanisms in corpus striatum and amphetamine-induced stereotyped behaviour. Psychopharmacologia 11, 179–183.
- Fog, R., A. Randrup, & H. Pakkenberg (1968 a): Chlorpromazine and related neuroleptic drugs in relation to the corpus striatum in rats. In: The Present Status of Psychotropic Drugs. ( A. Cerletti, & F. Bové, Eds.). Elsevier, Amsterdam , 278–280.
- Fog, R., A. Randrup & H. Pakkenberg (1968 b): Neuroleptic action of quaternary chlorpromazine and related drugs injected into various brain areas in rats. Psychopharmacologia (Berl.) 12, 428–432.
- Fog, R., A. Randrup & H. Pakkenberg (1969): Intracerebral microinjections of dopamine and amphetamine and their behavioural effects in rats. Paper read at the 3. Annual Meeting of the Scandinavian Society of Biological Psychiatry, Aarhus (Denmark), May 1969.
- Fog, R., A. Randrup & H. Pakkenberg (1971): Intrastriatal injection of quaternary butyrophenones and oxypertine: neuroleptic effects in rats. Psychopharmacologia 19, 224–230.
- Friedhoff, A. J. & E. van Winkle (1962): Isolation and characterization of a compound from the urine of schizophrenics. Nature (Lond.) 194, 897–898.
- Fuxe, K. & N.-E. Andén (1966): Studies on central monoamine neurons with special reference to the nigro-neostriatal dopamine neuron system. In: Biochemistry and Pharmacology of the Basal Ganglia ( E. Costa, L. J. Coté, and M. D. Yahr, Eds.). Raven Press, N. Y. , 123–130.
- Fuxe, K. & U. Ungerstedt (1970): Histochemical, biochemical and functional studies on central monoamine neurons after acute and chronic amphetamine administration. Symposium on Amphetamines and Related Compounds. ( E. Costa and S. Garattini, Eds.). Raven Press, N. Y. , 257–288.
- Garattini, S. & L. Valzelli (1965): Serotonin, Appendix V. Elsevier, Amsterdam .
- Goodwin, F., K. Brodie, D. Murphy & W. Bunney (1970): Administration of a peripheral decarboxylase inhibitor with 1-dopa to depressed patients. Lancet 1, 908–911.
- Griffith, J. D., J. H. Cavanaugh, J. Held & J. Oates (1970): Experimental psychosis induced by the administration of d-amphetamine. Symposium on Amphetamine and Related Compounds. ( E. Costa and S. Garattini, Eds.). Raven Press, N. Y. , 897–904.
- Gunne, L.-M. (1963): Catecholamines and 5-hydroxytryptamine in morphine tolerance and withdrawal. Thesis, Acta Physiol. Scand. 58, suppl. 204.
- Gunne, L.-M. (1965): Some pharmacological agents modyfying the morphine abstinence syndrome in dogs. Arch. int. Pharmacodyn. 157, 293–298.
- Gunne, L. & T. Lewander (1966): Monoamines in brain and adrenal glands of cats after electrically induced defense reaction. Acta Physiol. Scand. 67, 405–410.
- Halpern, M. & M. Lyon (1965): The effect of midbrain central grey-matter lesions upon an escape-avoidance response to shock in the rat. Proc. Amer. psychol. Ass. 1, 145–146.
- Hansson, L. C. F. (1965): Evidence that the central action of amphetamine is mediated via catecholamines. Psychopharmacologia (Berl.) 9, 78–80.
- Hansson, L. C. F. (1967): Evidence that the central action of (+)-amphetamine is mediated via catecholamines. Psychopharmacologia 10, 289–297.
- Hauschild, F. (1939): Zur Pharmakologie des 1-phenyl-2-methylaminopropans (Pervitin). Arch. exp. Path. Pharmak. 191, 465–481.
- Herman, Z. S. (1967): Influence of some psychotropic and adrenergic blocking agents upon amphetamine stereotyped behaviour in white rats. Psychopharmacologia 11, 136–142.
- Hoffer, A., H. Osmond & J. Smythies (1954): Schizophrenia: a new approach II. Results of a year's research. J. ment. Sci. 100, 29–45.
- Hornykiewicz, O. (1966): Dopamine (3-hydroxytyramine) and brain function. Pharmacol. Rev. 18, 925–964.
-
Hornykiewicz, O. (1968): Gegenwärtiger Stand der biochemisch-pharmakologischen Erforschung des extrapyramidal-motorischen Systems.
Pharmakopsychiat. Neuro-Psychopharmakol.
1, 6–17.
10.1055/s-0028-1094204 Google Scholar
-
Jaccbsen, E. (1963): The clinical pharmacology of the hallucinogens.
Clin. Pharmacol. Therap.
4, 480–503.
10.1002/cpt196344480 Google Scholar
- Janssen, P., C. Niemegeers & K. Schellekens (1965): Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data Drug Res. (Arzneim.-Forsch.) 15, 104–117.
- Janssen, P., C. Niemeegers, K. Schellekens & F. M. Lenaertz (1967): Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data Drug Res. (Arzneim.-Forsch.) 17, 841–854.
- Jonas, W. & J. Scheel-Krüger (1969): Amphetamine induced stereotyped behaviour correlated with the accumulation of O-methylated dopamined. Arch. int. Pharmacodyn. Therap. 177, 379–389.
- Jong, H. de (1931): Hormonale experimentelle Katatonie. Proc. Roy. Acad. Sci. (Amsterdam) 34, 576–587.
- Jönsson, L.-E., L.-M. Gunne & E. Anggård (1969): Effects of alphamethyltyrosine in amphetamine-dependent subjects. Pharmacol. clin. 2, 27–29.
-
Juorio, A. V. &
M. Vogt (1967): Monoamines and their metabolites in the avian brain.
J. Physiol. (Lond.)
189, 459–518.
10.1113/jphysiol.1967.sp008181 Google Scholar
- Kalant, O. J. (1966): The Amphetamines. University of Toronto Press, Canada .
- Karli, P. (1960): Troubles du comportement induit chez le rat par l'amphétamine et le phénidylate (Ritaline). Arch. int. Pharmacodyn. Ther. 122, 344–351.
-
Katona, F. &
M. Wolleman (1964): The effects of phenothiazines on some invertebrate animals. In: Comparative Neurochemistry ( S. Carter and
F. Williams, Eds.) Pergamon Press,
London
, 445–450.
10.1016/B978-0-08-010465-2.50043-6 Google Scholar
- Kelleher, R. T. & W. H. Morse (1964): Escape behavior and punished behavior. Fed. Proc. 23 (II) 808–816.
- Kindwall, E. P. & N. Wiener (1966): The distribution and rates of formation of catecholamines in several regions of bovine brain. J. Neurochem. 13, 1523–1531.
- Kjellberg, B. & A. Randrup (1969): Various forms of stereotyped, abnormal behaviour induced by amphetamine in primates. Acta Physiol. Scand. 65, suppl. 330.
- Kjellberg, B. & A. Randrup (1970): The effect of amphetamine and pimozide, a neuroleptic, on the social behaviour of vervet monkeys. Proceedings of the 7th Congress of the Collegium Internationale Neuro-Psychopharmacologicum, Prague. In press.
- K. Kolle, (Ed.) (1960): Grosse Nervenärzte. Georg Thieme Verleg, Stuttgart , 45–64.
- Kramer, J. C., V. S. Fischman, & D. C. Littlefield (1967): Amphetamine abuse. J. Am. med. Ass. 201, 305–309.
- Lapin, I. P. (1967): Simple pharmacological procedures to differentiate antidepressants and cholinolytics in mice and rats. Psychopharmacologia (Berl.) 11, 79–87.
-
Lapin, I. &
E. Schelkunov (1965): Amphetamine-induced changes in behaviour of small laboratory animals as simple tests for evaluation of central effects of new drugs. In: Pharmacology of conditioned learning and retention ( M. Mikhelson and
V. Longo, Eds.) Pergamon Press,
London
, 205–215.
10.1016/B978-1-4831-9847-7.50022-9 Google Scholar
- Lát, J. (1965): The spontaneous exploratory reactions as a tool for psychopharmacological studies. Proceedings of the 2nd International Pharmacological Meeting. ( M. Mikhelson and V. Longo, Eds.) Pergamon Press, London , Vol. 1, 47–66.
- Laverty, R. & D. F. Sharman (1965): Modification by drugs of the metabolism of 3,4-dihydroxyphenylethylamine, noradrenaline and 5-hydroxytryptamine in the brain. Brit. J. Pharmacol. Chemother. 24, 759–772.
- Leslie, G. B. & D. R. Maxwell (1964): Some pharmacological properties of thioproperazine and their modification by antiparkinson drugs. Brit. J. Pharmacol. 22, 301–317.
- Lingjœrde, O. (1966): Psykofarmaka (Norwegian). Grundt-Tanum, Oslo , Norway .
- Lyon, M. (1964): The role of central midbrain structures in conditioned responding to aversive noise in the rat. J. comp. Neurol. 122, 407–429.
- Lyon, M. & A. Randrup (1971): The dose-response effect of amphetamine upon avoidance behaviour in the rat seen as a function of increasing stereotypy. Psychopharmacologia (Berl.). In press.
- Maj, J. & E. Przegalinski (1967): Disulfiram and some effects of amphetamine in mice and rats. J. Pharm. Pharmacol. 19, 341–343.
- Mandell, A., C. Markham & W. Fowler (1961): Parkinson's syndrome, depression and imipramine. Calif. Med. 95, 12–14.
- Mann, P. & J. Quastel (1940): Benzedrine and brain metabolism. Biochem. J. 34, 414–420.
- Martin, W., A. Wikler, C. Eades & F. Pescor (1963): Tolerance to and physical dependence on morphine in rats. Psychopharmacologia (Berl.) 4, 247–260.
- Mattson, R. H. & J. R. Calverley (1968): Dextroamphetaminesulphate induced dyskinesias. J. Am. med. Ass. 204, 108–109.
- Molina, F. de & R. W. Hunsperger (1962): Organization of the subcortical system governing defence and flight reactions in the cat. J. Physiol. 160, 200–213.
- Moore, K. (1963): Toxicity of catecholamine releasing actions of d- and 1-amphetamine in isolated and aggregated mice. J. Pharmacol. exp. Ther. 142, 6–12.
- Morpurgo, C. (1962): Effects of antiparkinson drugs on a phenothiazine induced catatonic reaction. Arch. int. Pharmacodyn. 137, 84–90.
- Morpurgo, C. & W. Theobald (1964): Influence of antiparkinson drugs and amphetamine on some pharmacological effects of phenothiazine derivatives used as neuroleptics. Psychopharmacologia (Berl.) 6, 178–191.
- Müller-Calgan, H. & R. Hotovy (1961): Verhaltensänderungen der Katze durch verschiedene zentralerregend wirkende Pharmaka. Drug Res. (Arzneim. Forsch.) 11, 642–649 and 775–783.
- Munkvad, I. (1970): Neuroleptics in the treatment of schizophrenia. In: Modern Problems of Pharmacopsychiatry (Neuroleptics) ( J. Bobon and P. Janssen, Eds.). S. Karger, Basel , 44–47.
- Munkvad, I. & A. Randrup (1966): The persistence of amphetamine stereotypy of rats in spite of strong sedation. Acta Psychiat. Scand. 42 (suppl. 191), 178–187.
- Munkvad, I., H. Pakkenberg & A. Randrup (1968): Aminergic systems in basal ganglia associated with stereotyped, hyperactive behaviour and catalepsy. Brain, Behav Evol. 1, 89–100.
- Munkvad, I., G. Hein & B. Herskin (1970): Treatment of chronic schizophrenic patients with pimozide. Proceedings of the 7th Congress of the Collegium Internationale Neuro-Psychopharmacologicum, Prague. In press.
- Neal, M. (1968): Failure of morphine dependence in rats to influence brain noradrenaline turnover. J. Pharm. Pharmacol. 20, 950.
- Nilakantan, B. & A. Randrup (1968): Phylogenetic approach to the study of brain mechanisms involved in the action of amphetamine and other drugs. The Present Status of Psychotropic Drugs ( A. Cerletti and F. Bové, Eds.). Elsevier, Amsterdam , 263–265.
- Norton, S. (1967): An analysis of cat behaviour using chlorpromazine and amphetamine. Int. J. Neuropharmacol. 6, 307–316.
- Nueten, J.-M. van (1962): Étude des effects de dérivés phénothiaziniques et butyrophénoniques sur l'action de l'amphétamine chez le rat. Thesis, Paris.
- Nybäck, H., G. Sedwall & I. J. Kopin (1967): Accelerated synthesis of dopamine-C14 from tyrosine-C14 in rat brain after chlorpromazine. Life Sci. 6, 2307–2312.
- Pakkenberg, H. (1969): L-dopa og parkinsonisme. Ugeskr. f. Læger (Danish) 131, 959–960.
- Panse, F. (1942): Die Erbchorea. G. Thieme Verlag, Leipzig , 5–122.
- Pedersen, V. (1967): Potentiation of apomorphine effects (compulsive gnawing behaviour) in mice. Acta Pharmacol. Toxicol. 25, suppl. 4, 63.
- Pedersen, V. (1968): Role of catecholamines in compulsive gnawing behaviour in mice. Brit. J. Pharmacol. 34, 219.
- Petersen, P. V. (1951): Studies on a new spasmolytic compound 1,1-diphenyl-3-dimethylaminobutene-1 (A-29), related to methadone, and on the combined use of this compound and a potent analgesic, ketobemidone (A 21). Acta Pharmacol. (Kbh.). 7, 51–64.
-
Pfeiffer, C. C. &
J. E. H. Jenny (1957): The inhibition of the conditioned response and the counteraction of schizophrenia by muscarinic stimulation of the brain.
Ann. N. Y. Aca. Sci.
66, 753–764.
10.1111/j.1749-6632.1957.tb40764.x Google Scholar
- Phillips, M. I. & P. B. Bradley (1969): The effect of chlorpromazine and d-amphetamine mixtures on spontaneous behaviour. Int. J. Neuropharmacol. 8, 169–176.
- Pohlmeyer, H. & N. Matussek (1965): Untersuchungen über den Einfluss von Desmethyl-Imipramin auf den Parkinsonismus beim Menschen. Arch. Psychiat. Nervenkrankh. 207, 174–184.
- Poirier, L., T. L. Sourkes, G. Bouvier, R. Boucher & S. Carabin (1966): Striatal amines, experimental tremor and the effects of harmaline in the monkey. Brain 89, 37–52.
- Prada, M. da & A. Pletscher (1966): On the mechanism of chlorpromazine-induced changes of cerebral homovanillic acid levels. J. Pharm. Pharmacol. 18, 628–630.
- Quinton, R. & G. Halliwell (1963): Effects of α-methyl dopa and dopa on the amphetamine excitatory response in reserpinized rats. Nature 200, 178–179.
- Randrup, A. (1970): Role of brain dopamine in the antipsychotic effect of neuroleptics. Evidence from studies of amphetamine-neuroleptic interaction. Modern Problems of Pharmacopsychiatry (Neuroleptics) ( J. Bobon and P. Janssen, Eds.). S. Karger, Basel , 65–67.
- Randrup, A. & I. Munkvad (1960): On the measurement of adrenocrome in blood. Amer. J. Psychiat. 117, 153.
- Randrup, A. & I. Munkvad (1964): On the relation of tryptaminic and serotonergic mechanisms to amphetamine induced abnormal behaviour. Acta Pharmacol. Toxicol. 21, 272–282.
- Randrup, A. & I. Munkvad (1965): Special antagonism of amphetamine-induced abnormal behaviour. Psychopharmacologia (Berl.) 7, 416–422.
- Randrup, A. & I. Munkvad (1966 a): Dopa and other naturally occurring substances as causes of stereotypy and rage in rats. Acta Psychiat. Scand. 42 (suppl. 191), 193–199.
- Randrup, A. & I. Munkvad (1966 b): Role of catecholamines in the amphetamine excitatory response. Nature (Lond.) 211, 540.
- Randrup, A. & I. Munkvad (1967 a): Stereotyped activities produced by amphetamine in several animal species and man. Psychopharmacologia (Berl.) 11, 300–310.
- Randrup, A. & I. Munkvad (1967 b): Various forms of stereotyped activity produced by amphetamine in certain animal species and man. Neuro-Psychopharmacology, vol. 5, p. 1224. ( H. Brill, J. O. Cole, P. Deniker, H. Hippius and P. B. Bradley, Eds.). Elsevier, Amsterdam .
-
Randrup, A. &
I. Munkvad (1968): Behavioural stereotypies induced by pharmacological agents.
Pharmakopsychiat.-Neuro-Psychopharmakol.
1, 18–26.
10.1055/s-0028-1094205 Google Scholar
- Randrup, A. & I. Munkvad (1969): Pharmacological studies on the brain mechanisms underlying two forms of behavioural excitation: stereotyped hyperactivity and “rage”. Experimental Approaches to the Study of Emotional Behaviour (E. Tobach, Ed.). Ann. N. Y. Aca. Sci. 159, 928–938.
- Randrup, A. & I. Munkvad (1970 a): Biochemical, anatomical and psychological investigations of stereotyped behaviour induced by amphetamines. Symposium on Amphetamines and Related Compounds ( E. Costa and S. Garattini, Eds.) Raven Press, New York , 695–713.
- Randrup, A. & I. Munkvad (1970 b): Correlation between specific effects of amphetamines on the brain and on behavior. Symposium on Current Concepts of Amphetamine Abuse ( E. Ellinwood, Ed.) Duke University Press, USA . In press.
- Randrup, A. & I. Munkvad (1970 c): Behavioural toxicity of amphetamines studied by animal experiments. Correlation of Adverse Effects in Man with Observations in Animals. (S. B. de Baker, Ed.). Exc. Med. Int. Congr. Ser. No. 220. Amsterdam, pp. 6–17.
- Randrup, A. & J. Scheel-Krüger (1966): Diethyldithiocarbamate and amphetamine stereotyped behaviour. J. Pharm. Pharmacol. 18, 752.
- Randrup, A. & W. Jonas (1967): Brain dopamine and the amphetamine-reserpine interaction. J. Pharm. Pharmacol. 19, 483.
- Randrup, A., I. Munkvad & P. Udsen (1963): Adrenergic mechanisms and amphetamine induced abnormal behaviour. Acta Pharmacol. Toxicol. 20, 145–157.
- Reis, D. J. & K. Fuxe (1968): Depletion of noradrenaline in brain stem neurons during sham rage behaviour produced by acute brain stem transection in cat. Brain Res. 7, 448–451.
- Rio, J. del & J. A. Fuentes (1969): Further studies on the antagonism of stereotyped behaviour induced by amphetamine. Europ. J. Pharmacol. 8, 73–78.
- Robertis, E. de (1971): Binding of psychotropic drugs to subcellular fractions of the brain. In preparation (cited in Andén et al. (1970).
- Rossum, J. M. van (1966): The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs. Arch. int. Pharmacodyn. 160, 492–494.
- Rossum, J. M. van (1970): Mode of action of psychomotor stimulant drugs. International Review of Neurobiology. ( C. C. Pfeiffer and J. R. Smythies, Eds.). Academic Press, N. Y. 307–383.
- Rossum, J. M. van, J. B. van der Schoot & J. Hurkmans (1962): Mechanism of action of cocaine and amphetamine in the brain. Experientia 18, 229–231.
- Rossum, J. M. van, J. R. Boissier, P. A. J. Janssen, L. Julou, D. M. Loew, I. Møller Nielsen, I. Munkvad, A. Randrup, G. Stille & D. H. Tedeschi (1970): Pharmacology of neuroleptic drugs. Modern Problems of Pharmacopsychiatry (Neuroleptics) ( J. Bobon and P. Janssen, Eds.). S. Karger, Basel 23–33.
- Routtenberg, A., J. Sladek & W. Bondareff (1968): Histochemical fluorescence after application of neurochemicals to caudate nucleus and septal area in vivo. Science 161, 272–274.
- Rylander, G. (1966 a): Addiction to preludin intravenously injected. Proceedings of the IV World Congress of Psychiatry ( J. J. Lopez-Ibor, Ed.). Elsevier, Amsterdam , 1363–1365.
- Rylander, G. (1966 b): Preludin-narkomaner från klinisk och medisinsk-kriminologisk synpunkt. Svenska Läkartidningen (Swedish) 63, 4973–4980.
- Rylander, G. (1969): Clinical and medico-criminological aspects of addiction to central stimulating drugs. Abuse of Central Stimulants ( F. Sjöquist and M. Tottie, Eds.). Almquist and Wiksell, Stockholm , 251–262.
- Rylander, G. & M. Holmberg (1970): Stereotype behaviour in man following amphetamine abuse. Symposium on Addiction and Tolerance to Amphetamines (A. Liljestrand, Ed.) Uppsala (Sweden) 258–262.
- Sabelli, H., J. Lewin & J. Toman (1961): Interactions of imipramine and autonomic agents. Fed. Proc. 20 (1) 393.
- Schaumann, W. & H. G. Kurbjuweit (1961): Beeinflussung verschiedener Wirkungen von Thiopropazat durch ein zentrales Stimulans. Arzneim. Forsch. 11, 343–350.
- Scheel-Krüger, J. (1970 a): Central effects of anticholinergic drugs measured by the apomorphine gnawing test in mice. Acta Pharmacol. Toxicol. 28, 1–16.
- Scheel-Krüger, J. (1970 b): Behavioural hyperactivities in reserpinized rats correlated with a central cholinergic mechanism. Proceedings of the 7th Congress of Collegium Internationale Neuro-Psychopharmacologicum, Prague. In press.
- Scheel-Krüger, J. (1971): Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain. Europ. J. Pharmacol. 14, 47–59.
- Scheel-Krüger, J. & A. Randrup (1967): Stereotyped, hyperactive behaviour produced by dopamine in the absence of noradrenaline. Life. Sci. 6, 1389–1398.
- Scheel-Krüger, J. & A. Randrup (1968 a): Aggressive behaviour provoked by pargyline in rats pretreated with diethyldithiocarbamate. J. Pharm. Pharmacol. 20, 948–949.
- Scheel-Krüger, J. & A. Randrup (1968 b): Pharmacological evidence for a cholinergic mechanism in brain involved in a special stereotyped behaviour of reserpinized rats. Brit. J. Pharmacol. 34, 217.
- Scheel-Krüger, J. & A. Randrup (1969): Evidence for a cholinergic mechanism in brain involved in the tetrabenazine reversal by thymoleptic drugs. J. Pharm. Pharmacol. 21, 403–406.
- Schelkunov, E. L. (1964): The technique of “phenamine stereotypy” for evaluating the effect produced by remedial agents on the central adrenergic processes. Pharmacologia et Toxicologia (Russian). 27, 628–633.
- Schiørring, E. (1969): Amfetamin - i focus for forskning og misbrug (Danish). Mentalhygiejne 22, 13–20.
- Schiörring, E. (1971): Amphetamine induced selective stimulation of certain behaviour items with concurrent inhibition of others in an open-field test with rats. Behaviour 39 (1), 1–17.
- Schiørring, E. & A. Randrup (1968): “Paradoxical” stereotyped activity of reserpinized rats. Int. J. Neuropharmacol. 7, 71–73.
-
Schiørring, E. &
A. Randrup (1971): Social isolation and changes in the formation of groups induced by amphetamine in an open-field test with rats.
Pharmakopsychiat.-Neuropsychopharmakol.
4, 2–12.
10.1055/s-0028-1094292 Google Scholar
- Sharman, D. F. (1966): The turnover of 3,4-dihydroxyphenylethylamine (dopamine) in the brain. J. Physiol. (Lond.). 186, 69–70.
- Sharman, D. F., L. J. Poirier, G. F. Murphy & T. L. Sourkes (1967): Homovanillic acid and dihydroxyphenylacetic acid in the striatum of monkeys with brain lesions. Canad. J. physiol. Pharm. 45, 57–62.
- Silverman, A. P. (1963): The effect of drugs on the social behaviour of the laboratory rat. Thesis, Birmingham, U. K..
- Silverman, A. P. (1966): Social behaviour of rats and the action of drugs. Behaviour 27, 1–38.
- Stein, L. (1964): Self-stimulation of the brain and the central stimulant action of amphetamine. Fed. Proc. 23, 836–850.
- Stille, G. & A. Sayers (1969): Effect of a striatal spreading depression on the pharmacogenic catatonia. Int. J. Neuropharmacol. 8, 181–189.
- Strömgren, E. (1959): Discussion (4. symposium). Neuro-Psychopharmacology ( P. Bradley, P. Deniker, and C. Radonco-Thomas, Eds.) Elsevier, Amsterdam , 183–185.
- Sulser, F. & E. Sanders-Bush (1970): Biochemical and metabolic considerations concerning the mechanism of action of amphetamine and related compounds. Psychotomimetic Drugs. ( D. H. Efron, Ed.). Raven Press, N. Y. , 83–94.
- Taeschler, M., A. Fanchamps & A. Cerletti (1960): Zur Bedeutung verschiedener pharmakodynamischer Eigenschaften der Phenothiazinderivate für ihre klinische Wirksamkeit. Psychiat. Neurol. (Basel) 139, 85–104.
- Taeschler, M., H. Weidmann & A. Cerletti (1962): Zur Pharmakologie von Pronalid, einem neuen zentralen Antikolinergikum. Schweiz. med. Wschr. 90, 1542–1545.
- Teitelbaum, P. & P. Derks (1958): The effect of amphetamine on forced drinking in the rat. J. comp. physiol. Psychol. 51, 801–810.
- Theobald, W., O. Büch, H. A. Kunz, C. Morpurgo, E. G. Stenger & G. Wilhelm (1964): Vergleichende pharmakologische Untersuchungen mit Tofranil, Pertofran und Insidon. Arch. int. Pharmacodyn. 148, 560–596.
- Tour, M. de (1845): Du haschisch et de l'aliéniation mentale. Paris.
- Ungerstedt, U. (1969): Behavioural registration of dopamine synaptic activity in the brain after 6-hydroxy-dopamine lesions. Acta Physiol. Scand. suppl. 330, 117.
- Ungerstedt, U., L. Butcher, S. Butcher, N.-E. Andén & K. Fuxe (1969): Direct chemical stimulation of dopaminergic mechanisms in the neostriatum of the rat. Brain Res 14, 461–471.
-
Utena, H. (1966): Behavioral aberrations in metamphetamine-intoxicated animals and chemical correlates in the brain.
Progr. Brain Res.
21 B, 192–207.
10.1016/S0079-6123(08)64231-4 Google Scholar
- Vane, J. (1960): The actions of sympathomimetic amines on tryptamine receptors. Adrenergic Mechanisms ( J. Vane, G. Wolstenholme and M. O'Connor, Eds.). Churchill, London , 356–372.
- Verhave, T. (1958): The effect of metamphetamine on operant level and avoidance behaviour. J. exp. anal. Behav. 1, 207–219.
- Verri, R. A. (1967): Antagonism of morphine analgesia by reserpine and α-methyltyrosine and the role played by catecholamines in morphine analgesic action. J. Pharm. Pharmacol. 19, 264.
- Weissman, A., B. Koe & S. Tenen (1966): Antiamphetamine effects following inhibition of tyrosine hydroxylase. J. Pharmacol. exp. Therap. 151, 339–352.
- Zetler, G. (1968): Cataleptic state and hypothermia in mice caused by central cholinergic stimulation and antagonized by anticholinergic and antidepressant drugs. Int. J. Neuropharmacol. 7, 325–335.
- Zetler, G. & U. Otten (1969): Aggresivität der Ratte nach kombinierte Behandlung mit Monoaminooxydaseinhibitoren und anderen psychotropen Pharmaka, insbesondere Thymoleptika. Naunyn Schmied. Arch. Pharm. 264, 32–54.